Literature DB >> 20447852

Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases.

Cécile Wibaux1, Irina Andrei, Julien Paccou, Peggy Philippe, Emmanuel Biver, Bernard Duquesnoy, René Marc Flipo.   

Abstract

We report two cases of pregnancy in patients taking TNFalpha antagonists for chronic inflammatory joint disease. A factor in both pregnancies was the use of rifampin concomitantly with a combined oral contraceptive. Both patients were taking rifampin and isoniazid for tuberculosis prophylaxis in compliance with French recommendations for patients with positive intradermal tuberculin tests who are scheduled to receive biotherapeutic agents. Copyright 2010. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447852     DOI: 10.1016/j.jbspin.2010.02.001

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  1 in total

Review 1.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.